Skip to main content

Table 4 Comparison between LV function, ECV and myocardial strain before and after 6-months anti-hypertension drug therapy

From: Sensitive marker for evaluation of hypertensive heart disease: extracellular volume and myocardial strain

 Before treatmentAfter treatmentP value
EF44.6 ± 22.352.4 ± 18.90.02
 LVEDVI (ml/m2)96.9 (67.7)74.8 (40.1)0.06
 LVSVI (ml/m2)40.0 ± 16.440.1 ± 13.80.85
 LVMI(g/m2)106.5 (31.2)97.6 (36.2)0.18
 EDWT (cm)1.2 (0.2)1.1 (0.3)0.03
ECV
 Mean0.27 (0.04)0.25 (0.04)0.000
 Base0.29 ± 0.040.25 ± 0.040.000
 Middle0.25 (0.01)0.24 (0.01)0.001
 Apex0.25 (0.01)0.24 (0.01)0.71
RS
 Global16.8 ± 8.922.7 ± 9.50.01
 Base20.7 ± 11.129.5 ± 16.70.06
 Middle11.0 (17.0)20.2 (14.3)0.027
 Apex13.6 (17.9)20.4 (22.3)0.64
CS
 Global−13.4 ± 5.6−16.0 ± 4.60.03
 Base−9.9 (10.5)−10.9 (7.8)0.02
 Middle−12.0 (11.9)−17.4 (8.3)0.16
 Apex−16.2 ± 6.5−19.6 ± 5.20.05
LS
 Global−6.9 (6.0)−9.0 (5.4)1.00
 Base−5.4 (5.0)−5.2 (13.1)0.13
 Middle−6.4 (6.4)−8.7 (5.8)0.50
 Apex−10.7 (8.0)−12.0 (6.3)0.12